The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Urinary Angiotensin-Converting Enzyme 2 in Hypertensive Patients May Be Increased by Olmesartan, an Angiotensin II Receptor Blocker
Open accessAbstract
BACKGROUND: Angiotensin-converting enzyme 2 (ACE2) is highly expressed in the kidney and converts angiotensin (Ang) II to Ang-(1-7), a renoprotective peptide. Urinary ACE2 has been shown to be elevated in patients with chronic kidney disease. However, the effects of antihypertensive agents on urinary ACE2 remain unclear. METHODS: Of participants in the Tanno-Sobetsu cohort study in 2011 (n = 617), subjects on no medication (n = 101) and hypertensive patients treated with antihypertensive agents, including the calcium channel blockers amlodipine and long-acting nifedipine; the ACE inhibitor enalapril; and the Ang II receptor blockers losartan, candesartan, valsartan, telmisartan, and olmesartan, for more than 1 year (n = 100) were enrolled, and urinary ACE2 level was measured. RESULTS: Glucose and hemoglobin A1c were significantly higher in patients treated with enalapril, telmisartan or olmesartan than in the control subjects. Urinary albumin-to-creatinine ratio (UACR) was significantly higher in patients treated with enalapril than in the control subjects. Urinary ACE2 level was higher in the olmesartan-treated group, but not the other treatment groups, than in the control group. Urinary ACE2 level was positively correlated with systolic blood pressure (r = 0.211; P = 0.003), UACR (r = 0.367; P < 0.001), and estimated salt intake (r = 0.260; P < 0.001). Multivariable regression analysis after adjustment of age, sex, and the correlated indices showed that the use of olmesartan was an independent predictor of urinary ACE2 level. CONCLUSIONS: In contrast with other antihypertensive drugs, olmesartan may uniquely increase urinary ACE2 level, which could potentially offer additional renoprotective effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Revised Equations for Estimated GFR From Serum Creatinine in Japan
Matsuo, S., Imai, E., Horio, M., Yasuda, Y., Tomita, K., Nitta, K., Yamagata, K., Tomino, Y., Yokoyama, H., & Hishida, A. (2009) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.12.034 · Cited by 6,422
Donoghue, M., Hsieh, F., Baronas, E., Godbout, K., Gosselin, M., Stagliano, N., Donovan, M., Woolf, B., Robison, K., Jeyaseelan, R., et al. (2000) · Circulation Research · doi:10.1161/01.res.87.5.e1 · Cited by 2,485
A Human Homolog of Angiotensin-converting Enzyme
Tipnis, S. R., Hooper, N. M., Hyde, R., Karran, E., Christie, G., & Turner, A. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002615200 · Cited by 2,009
Angiotensin-converting enzyme 2 is an essential regulator of heart function
Crackower, M. A., Sarao, R., Oudit, G. Y., Yagil, C., Kozieradzki, I., Scanga, S. E., Oliveira-dos-Santos, A. J., da Costa, J., Zhang, L., Pei, Y., et al. (2002) · Nature · doi:10.1038/nature00786 · Cited by 1,733
Ishiyama, Y., Gallagher, P. E., Averill, D. B., Tallant, E. A., Brosnihan, K. B., & Ferrario, C. M. (2004) · Hypertension · doi:10.1161/01.hyp.0000124667.34652.1a · Cited by 564
The angiotensin–converting enzyme gene family: genomics and pharmacology
Turner, A. J., & Hooper, N. M. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01994-5 · Cited by 406
(2019) · Journal of Human Hypertension · doi:10.1038/41371.1476-5527 · Cited by 389
Characterization of Renal Angiotensin-Converting Enzyme 2 in Diabetic Nephropathy
Tikellis, C., Johnston, C. I., Forbes, J. M., Burns, W. C., Burrell, L. M., Risvanis, J., & Cooper, M. E. (2003) · Hypertension · doi:10.1161/01.hyp.0000060689.38912.cb · Cited by 350
ACE and ACE2 Activity in Diabetic Mice
Wysocki, J., Ye, M., Soler, M. J., Gurley, S. B., Xiao, H. D., Bernstein, K. E., Coffman, T. M., Chen, S., & Batlle, D. (2006) · Diabetes · doi:10.2337/db06-0033 · Cited by 339
Human Recombinant ACE2 Reduces the Progression of Diabetic Nephropathy
Oudit, G. Y., Liu, G. C., Zhong, J., Basu, R., Chow, F. L., Zhou, J., Loibner, H., Janzek, E., Schuster, M., Penninger, J. M., et al. (2010) · Diabetes · doi:10.2337/db09-1218 · Cited by 300
Wysocki, J., Ye, M., Rodriguez, E., González-Pacheco, F. R., Barrios, C., Evora, K., Schuster, M., Loibner, H., Brosnihan, K. B., Ferrario, C. M., et al. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.138420 · Cited by 300
Loss of Angiotensin-Converting Enzyme-2 (Ace2) Accelerates Diabetic Kidney Injury
Wong, D. W., Oudit, G. Y., Reich, H., Kassiri, Z., Zhou, J., Liu, Q. C., Backx, P. H., Penninger, J. M., Herzenberg, A. M., & Scholey, J. W. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.060977 · Cited by 273
Ferrario, C. M., Jessup, J., Gallagher, P. E., Averill, D. B., Brosnihan, K. B., Ann Tallant, E., Smith, R. D., & Chappell, M. C. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00675.x · Cited by 259
Oudit, G. Y., Herzenberg, A. M., Kassiri, Z., Wong, D., Reich, H., Khokha, R., Crackower, M. A., Backx, P. H., Penninger, J. M., & Scholey, J. W. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.051091 · Cited by 232
Ye, M., Wysocki, J., Naaz, P., Salabat, M. R., LaPointe, M. S., & Batlle, D. (2004) · Hypertension · doi:10.1161/01.hyp.0000126192.27644.76 · Cited by 221
Soler, M. J., Wysocki, J., Ye, M., Lloveras, J., Kanwar, Y., & Batlle, D. (2007) · Kidney International · doi:10.1038/sj.ki.5002373 · Cited by 217
Warner, F. J., Lew, R. A., Smith, A. I., Lambert, D. W., Hooper, N. M., & Turner, A. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508914200 · Cited by 183
ACE2 and Ang-(1-7) Confer Protection Against Development of Diabetic Retinopathy
Verma, A., Shan, Z., Lei, B., Yuan, L., Liu, X., Nakagawa, T., Grant, M. B., Lewin, A. S., Hauswirth, W. W., Raizada, M. K., et al. (2012) · Molecular Therapy · doi:10.1038/mt.2011.155 · Cited by 159
Li, N., Zimpelmann, J., Cheng, K., Wilkins, J. A., & Burns, K. D. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00144.2004 · Cited by 155
Review: Angiotensin II type 1 receptor blockers: class effects versus molecular effects
Miura, S.-I., Karnik, S. S., & Saku, K. (2010) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320310370852 · Cited by 154
Shaltout, H. A., Westwood, B. M., Averill, D. B., Ferrario, C. M., Figueroa, J. P., Diz, D. I., Rose, J. C., & Chappell, M. C. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00139.2006 · Cited by 147
Kawano, Y., Tsuchihashi, T., Matsuura, H., Ando, K., Fujita, T., & Ueshima, H. (2007) · Hypertension Research · doi:10.1291/hypres.30.887 · Cited by 141
Agata, J., Ura, N., Yoshida, H., Shinshi, Y., Sasaki, H., Hyakkoku, M., Taniguchi, S., & Shimamoto, K. (2006) · Hypertension Research · doi:10.1291/hypres.29.865 · Cited by 132
Self-citationJessup, J. A., Gallagher, P. E., Averill, D. B., Brosnihan, K. B., Tallant, E. A., Chappell, M. C., & Ferrario, C. M. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00061.2006 · Cited by 128
Liu, C. X., Hu, Q., Wang, Y., Zhang, W., Ma, Z. Y., Feng, J. B., Wang, R., Wang, X. P., Dong, B., Gao, F., et al. (2010) · Molecular Medicine · doi:10.2119/molmed.2010.00111 · Cited by 127
Nadarajah, R., Milagres, R., Dilauro, M., Gutsol, A. A., Xiao, F., Zimpelmann, J., Kennedy, C., Wysocki, J. A., BATLLE, D. C., & Burns, K. D. (2012) · Kidney International · doi:10.1038/ki.2012.83 · Cited by 116
Regulation of urinary ACE2 in diabetic mice
Wysocki, J. A., Garcia-Halpin, L., Ye, M., Maier, C., Sowers, K. M. R., Burns, K. D., & BATLLE, D. C. (2013) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00600.2012 · Cited by 69
Angiotensin-converting enzyme 2: implications for blood pressure and kidney disease
Ingelfinger, J. R. (2008) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e32831b70ad · Cited by 67
Enhanced Angiotensin II-Induced Cardiac and Aortic Remodeling in ACE2 Knockout Mice
Alghamri, M. S., Weir, N. M., Anstadt, M. P., Elased, K. M., Gurley, S. B., & Morris, M. (2012) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248412460124 · Cited by 67
Urinary angiotensin‐converting enzyme 2 in patients with CKD
Mizuiri, S., AOKI, T., Hemmi, H., Arita, M., Sakai, K., & Aikawa, A. (2011) · Nephrology · doi:10.1111/j.1440-1797.2011.01467.x · Cited by 57
Park, S. E., Kim, W. J., Park, S. W., Park, J. W., Lee, N., Park, C., & Youn, B. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0782 · Cited by 49
Gavras, I., & Gavras, H. (1999) · Current Medical Research and Opinion · doi:10.1185/03007999909115169 · Cited by 48
Inaba, S., Iwai, M., Furuno, M., Kan‐no, H., Senba, I., Okayama, H., Mogi, M., Higaki, J., & Horiuchi, M. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e32834bbb4d · Cited by 32
Kurtz, T. W., & Pravenec, M. (2008) · American Journal of Hypertension · doi:10.1038/ajh.2008.202 · Cited by 26
Ono, T., Sanai, T., Miyahara, Y., & Noda, R. (2013) · Current Therapeutic Research · doi:10.1016/j.curtheres.2013.02.002 · Cited by 20
Cited by
Mechanisms of SARS-CoV-2 entry into cells
Jackson, C. B., Farzan, M., Chen, B., & Choe, H. (2022) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00418-x · Cited by 3,022
Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19
Vaduganathan, M., Vardeny, O., Michel, T., McMurray, J. J. V., Pfeffer, M. A., & Solomon, S. D. (2020) · New England Journal of Medicine · doi:10.1056/nejmsr2005760 · Cited by 2,101
COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives
Nishiga, M., Wang, D. W., Han, Y., Lewis, D. B., & Wu, J. C. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0413-9 · Cited by 1,409
Angiotensin receptor blockers as tentative SARS‐CoV‐2 therapeutics
Gurwitz, D. (2020) · Drug Development Research · doi:10.1002/ddr.21656 · Cited by 802
Sardu, C., Gambardella, J., Morelli, M. B., Wang, X., Marfella, R., & Santulli, G. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051417 · Cited by 592
Metadata
- Authors
- Furuhashi, M., Moniwa, N., Mita, T., Fuseya, T., Ishimura, S., Ohno, K., Shibata, S., Tanaka, M., Watanabe, Y., Akasaka, H., Ohnishi, H., Yoshida, H., Takizawa, H., Saitoh, S., Ura, N., Shimamoto, K., & Miura, T.
- Venue
- American Journal of Hypertension
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-05-18
- Volume
- 28
- Issue
- 1
- Pages
- 15-21
- ISSN
- 0895-7061 (ISSN-L)
- 1941-7225
- OpenAlex
- W2123906295
- Cited by
- 263
- References
- 35
- FWCI
- 1.47
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.